Medartis Inc. today announced the official U.S. launch of the TITAN Nail System, expanding the company’s upper extremity trauma portfolio with a intramedullary fixation solution designed to address…
KeriMedical (Medartis Group) has officially launched the first clinical study of the TOUCH® CMC 1 Prosthesis in a U.S. patient population (NCT #7405983). Dr. F. Thomas D. Kaplan, assisted by Dr.…
In the heart of Kosciusko County, apprenticeships have been developed due to the great opportunity for hands-on learning in the orthopedic manufacturing sector. These programs provide focused…
Your gateway to the Medartis knowledge world: Medartis ONE brings together product information, educational resources, and marketing materials in one central platform. Fast, intuitive, and always…
Jonathan Tueting, MD of Rush Orthopaedics & Sports Medicine in Aurora, Illinois performed the very first carpometacarpal (CMC) total joint arthroplasty in the United States this week using the TOUCH®…
Medartis reported total sales of CHF 123.0 million for H1 2025, representing growth of 14.1% at constant exchange rates (CER). Core sales reached CHF 122.1 million with organic growth of 15.3%. EMEA…
Following FDA approval of the KeriMedical TOUCH prosthesis on 10 July, the Medartis Group has decided to acquire the remaining 53% of the privately held company in accordance with the existing…
Medartis, a leading orthopedic company specializing in head and extremity surgery, announced the acquisition of the Avenger Radial Head System from In2Bones Global, Inc., a wholly owned subsidiary of…
Medartis today reported total sales of CHF 224.8 million for the full year 2024, representing growth of 8.5% at constant exchange rates (CER). Core sales increased 11.7% and reached CHF 219.6 million.…
